Literature DB >> 4109597

Enzymic removal and re-expression of a histocompatibility antigen, HL-A 2, at the surface of human peripheral lymphocytes ( 31 Cr-labeled cells-papain-puromycin-actinomycin D).

M J Turner, J L Strominger, A R Sanderson.   

Abstract

The removal by papain of a histocompatibility antigen, HL-A 2, from the surface of intact peripheral blood lymphocytes has been examined. Up to 80% of the antigenic determinant can be removed within 90 minutes. If the cells are reincubated in nutritive medium, re-expression of HL-A 2 is complete within 6 hours. Re-expression is reversibly inhibited by puromycin (50 mug/ml), but actinomycin D (6 mug/ml) only partially inhibited re-expression after 2 hours of prior incubation with the drug.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4109597      PMCID: PMC427575          DOI: 10.1073/pnas.69.1.200

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Release of soluble protein from reticulocyte ribosomes.

Authors:  A J MORRIS; R S SCHWEET
Journal:  Biochim Biophys Acta       Date:  1961-02-18

2.  Regeneration of transplantation antigens on mouse cells.

Authors:  B D Schwartz; S G Nathenson
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

3.  Advances in the chemistry of transplantation antigens.

Authors:  B D Kahan; R A Reisfeld
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

4.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Localization of mouse H-2 histocompatibility antigen with ferritin-labelled antibody.

Authors:  W C Davis; L Silverman
Journal:  Transplantation       Date:  1968-07       Impact factor: 4.939

6.  Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system.

Authors:  D A Davies; A J Manstone; D C Viza; J Colombani; J Dausset
Journal:  Transplantation       Date:  1968-07       Impact factor: 4.939

7.  HL-A substances from human spleens.

Authors:  A R Sanderson
Journal:  Nature       Date:  1968-10-12       Impact factor: 49.962

8.  Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells.

Authors:  A Cohen; M Schlesinger
Journal:  Transplantation       Date:  1970-07       Impact factor: 4.939

9.  Regeneration of sialic acid on the surface of Chinese hamster cells in culture. I. General characteristics of the replacement process.

Authors:  P M Kraemer
Journal:  J Cell Physiol       Date:  1966-08       Impact factor: 6.384

10.  Transplantation antigen of mice: cellular localization of antigen determined by the H-2 locus.

Authors:  G Haughton
Journal:  Transplantation       Date:  1966-05       Impact factor: 4.939

View more
  6 in total

1.  [The effext of papain, neuraminidase and AET on the behavior of lymphocytes in cytotoxicity tests].

Authors:  F W Bube; H Heumann; D Seegers; E Siebel
Journal:  Blut       Date:  1975-07

2.  Reversible transformation by urea of contact-inhibited fibroblasts.

Authors:  J A Weston; K L Hendricks
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

3.  H-2 antigens on nuclear membranes.

Authors:  W H Albert; D A Davies
Journal:  Immunology       Date:  1973-05       Impact factor: 7.397

4.  The degradation and turnover of fucosylated glycoproteins in the plasma membrane of a neuroblastoma-cell line.

Authors:  J E Hudson; T C Johnson
Journal:  Biochem J       Date:  1977-08-15       Impact factor: 3.857

5.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

Authors:  J A McCutcheon; J Gumperz; K D Smith; C T Lutz; P Parham
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

6.  Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours.

Authors:  R W Baldwin; D Glaves; B M Vose
Journal:  Br J Cancer       Date:  1974-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.